AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S. Pharmaceutical Investing
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients Pharmaceutical Investing
AbbVie Submits Biologics License Application to U.S. FDA for Pivekimab sunirine - an Investigational Antibody-Drug Conjugate to Treat Rare Cancer with Limited Treatment Options Pharmaceutical Investing
aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT Study in Late-Breaking Oral Abstract at the European Respiratory Society Congress 2025 Pharmaceutical Investing
AbbVie Breaks Ground on New North Chicago Active Pharmaceutical Ingredient Manufacturing Facility Pharmaceutical Investing
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA Pharmaceutical Investing
Telescope Innovations Produces Battery-Grade Lithium Carbonate from Recycled Waste Streams Pharmaceutical Investing
AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease Pharmaceutical Investing
Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors Pharmaceutical Investing
